30.03  0 (0%)		04-10 16:00
Open: 29.59 High: 30.07 Volume: 1		Pre. Close: 30.03 Low: 29.43 Market Cap: 83(M)

Short term
Mid term
Targets	6-month :	35.12	1-year :	41.02
Resists	First :	30.06	Second :	35.12
Pivot price	29.81
Supports	First :	29.43	Second :	29.04
MAs	MA(5) :	30.03	MA(20) :	29.71
	MA(100) :	23.41	MA(250) :	13.26
MACD	MACD :	0.3	Signal :	0.3
%K %D	K(14,3) :	96	D(3) :	96
RSI	RSI(14): 63.9
52-week	High :	30.06	Low :	4.58

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ NVCN ] has closed below upper band by 32.7%. Bollinger Bands are 74.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 51 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	30.1 - 30.25	30.25 - 30.37
Low:	29.61 - 29.82	29.82 - 29.98
Close:	29.74 - 30.05	30.05 - 30.3

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Tue, 11 Apr 2023
Shockwave Medical (NDAQ:SWAV) completes Neovasc (TSX:NVCN) acquisition - Stockhouse Publishing

Mon, 10 Apr 2023
Neovasc Inc Stock Quote | Stock Price for NVCN | FinancialContent Business Page - Financial Content

Thu, 09 Mar 2023
Neovasc's (TSE:NVCN) investors will be pleased with their solid 171% return over the last year - Yahoo Finance

Mon, 06 Mar 2023
Neovasc Shareholders Approve Acquisition by Shockwave Medical - Yahoo Finance

Tue, 17 Jan 2023
Shockwave Medical to Acquire Neovasc - Yahoo Finance

Tue, 17 Jan 2023
Neovasc stock soars ~30% as Shockwave set to acquire it in ~$100M deal - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	3 (M)
Shares Float	0 (M)
Held by Insiders	3.6 (%)
Held by Institutions	7.8 (%)
Shares Short	29 (K)
Shares Short P.Month	12 (K)

EPS	-15.07
EPS Est Next Qtrly	-0.08
EPS Est This Year	-0.35
EPS Est Next Year	-0.21
Book Value (p.s.)	10.22
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-2
PEG Ratio	0
Price to Book value	2.93
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	2019-07-01
Ex-Dividend Date	Invalid DateTime.